|
|
||||||||
Corrections |
Norman, J. P., S. W. Perry, K. A. Kasischke, D. J. Volsky, and H. A. Gelbard. 2007. HIV-1 Trans activator of transcription protein elicits mitochondrial hyperpolarization and respiratory deficit, with dysregulation of complex IV and nicotinamide adenine dinucleotide homeostasis in cortical neurons. J. Immunol. 178: 869876 .
Throughout the article, NAD(P)H should have been used in place of NADPH to signify both NADH and NADPH, and NAD(P)H should have been included with the standard abbreviations given in Footnote 3. The corrected footnote is shown below.
3 Abbreviations used in this paper: HAD, HIV-1-associated dementia; 
m, mitochondrial membrane potential;
p, proton motive force; ETC, electron transport chain; FCCP, carbonyl cyanide-4(trifluoromethoxy)phenylhydrazone; NMDA, N-methyl-D-asparate; pHm, mitochondrial pH; PTD, protein transduction domain; rhod123, rhodamine 123; Tat, trans activator of transcription protein; EYFP, enhanced yellow fluorescent protein; CFP, cyan fluorescent protein; NAD(P)H, signifies both NADH and NADPH.
In Results, in the fifth heading, the words "NAD+/NADH ratio and NADPH" are incorrect. Under that heading, in the fourth sentence of the second paragraph, the
symbol should have been uppercase. The corrected heading and sentence are shown below.
Effects of HIV Tat on NAD(P)H fluorescence
The effect was specific for Tat, because the application of
3161 Tat did not result in an observable fluorescence change.
The errors have been corrected in the online version, which now differs from the print version as originally published.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |